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Sin Nombre virus (SNV) and Andes virus (ANDV), members of the genus Hantavirus, in the family Bunyaviridae, are causative agents of
hantavirus pulmonary syndrome (HPS) in North and South America, respectively. Although ANDV causes a lethal HPS-like disease in
hamsters, SNV, and all other HPS-associated hantaviruses that have been tested, cause asymptomatic infections of laboratory animals,
including hamsters. In an effort to understand the pathogenicity of ANDV in the hamster model, we generated ANDV/SNV reassortant
viruses. Plaque isolation of viruses from cell cultures infected with both parental viruses yielded only one type of stable reassortant virus:
large (L) and small (S) segments of SNV and M segment of ANDV. This virus, designated SAS reassortant virus, had in vitro growth and
plaque morphology characteristics similar to those of ANDV. When injected into hamsters, the SAS reassortant virus was highly infectious
and elicited high-titer, ANDV-specific neutralizing antibodies; however, the virus did not cause HPS and was not lethal. These data indicate
that the ANDV M genome segment is not sufficient to confer the lethal HPS phenotype associated with ANDV.
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Hantaviruses are members of the Bunyaviridae family of
viruses. Bunyaviruses are small (80–120 nm), spherical,
enveloped viruses, with genomes consisting of three single-
stranded, negative-sense RNA molecules (Schmaljohn and
Dalrymple, 1983). Viral RNAs are defined as small (S),
medium (M), and large (L) segments that encode the
nucleocapsid protein, envelope glycoproteins, and viral
polymerase, respectively. Hantavirus infections are associ-
ated with two severe and sometimes fatal diseases in
humans: hemorrhagic fever with renal syndrome (HFRS)
and hantavirus pulmonary syndrome (HPS) (Lee et al.,
1982; Nichol et al., 1993). Almost 30 different hantaviruses
have been identified, over half of which are known to cause
disease in humans (Nichol, 2001).
Sin Nombre virus (SNV) is the most prevalent disease-
causing hantavirus in the United States. Since its appearance0042-6822/$ - see front matter D 2004 Published by Elsevier Inc.
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states. Despite the advanced health care that patients receive
in the United States, HPS has a greater than 37% case-
fatality rate (CDC, 2004). Andes virus (ANDV) is a related
but distinct hantavirus that is prevalent in areas of South
America (Castillo et al., 2001; Padula et al., 2000; Toro et
al., 1998). SNVand ANDV share 85.5%, 77.4%, and 86.6%
amino acid sequence homology in their S, M, and L open
reading frames, respectively (Clustal alignment). Both
viruses cause HPS with similar fatality rates in humans;
however, the clinical courses of these two viral diseases
differ slightly. Hemorrhagic manifestations and renal in-
volvement have been reported more frequently in ANDV-
associated HPS cases than in SNV-associated HPS cases
(Castillo et al., 2001; Duchin et al., 1994). ANDV is also of
significant concern to public health officials because it is the
only hantavirus that has documented person-to-person trans-
mission among family members and health-care workers
(Chaparro et al., 1998; Padula et al., 1998; Toro et al.,
1998).
The study of hantavirus pathogenesis and the develop-
ment of medical countermeasures have been severely limit-
ed by the absence of animal models of severe HFRS or HPS.
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neurological disease in newborn mice (Kim and McKee,
1985; McKee et al., 1985) and recently it was reported that
adult mice can develop a similar neurological disease
(Wichmann et al., 2002). Signs of mild HFRS have been
reported in nonhuman primates infected with Puumala virus,
a virus associated with mild HFRS in humans (Groen et al.,
1995; Klingstrom et al., 2002). HPS-causing hantaviruses
tested, in general, do not cause disease in laboratory animals
(Botten et al., 2000; Hutchinson et al., 1998, 2000). The
recent discovery that Syrian hamsters develop a lethal HPS-
like disease when infected with ANDV provided the first
model of severe hantavirus disease for any virus in the
Hantavirus genus (Hooper et al., 2001). In a later study,
Maporal virus, a hantavirus isolated from rodents in Vene-
zuela that is not known to cause disease in humans, also
caused an HPS-like disease in Syrian hamsters (Milazzo
et al., 2002).
The finding that ANDV causes lethal HPS in hamsters
while a closely related hantavirus, SNV, infects but is
asymptomatic (Hooper et al., 2001) led us to investigate
the possibility that ANDV/SNV reassortant viruses might
be used to map the virulent phenotype associated with
ANDV to a particular genome segment. Evidence of
naturally occurring reassortment among hantaviruses is
well documented (Henderson et al., 1995; Li et al.,
1995). In the laboratory, reassortants among closely related
hantaviruses have been generated (Ebihara et al., 2000;
Rodriguez et al., 1998). Investigators have been largely
unsuccessful at generating reassortant viruses from different
species of HFRS- or HPS causing hantaviruses. Kang et al.
(2002) reported the generation of diploid viruses derived
from HTNV and SEOV mixed infections and Rodriguez et
al. (1998) described the generation of a single reassortant
virus generated from cells co-infected with Black Creek
Canal (BCCV) and SNV. PCR analysis indicated that the
BCCV/SNV reassortant had the M segment of SNV and the
L and S segments of BCCV (Rodriguez et al., 1998). In
this study, we describe the generation and characterization
of an ANDV/SNV reassortant. We report the use of this
reassortant virus to investigate the role of the ANDV M
genome segment in HPS pathogenesis in the Syrian hams-
ter model.Fig. 1. Only one type of reassortant virus was obtained from co-infections of AND
various viruses. The restriction patterns are shown for the parental genotypes (ANResults and discussion
Co-infection of ANDV with SNV generated only one type of
recoverable reassortant virus
Vero E6 cells were co-infected with ANDV and SNV at
various multiplicities of infection. The progeny viruses were
twice-plaque purified, amplified, and then genetically
characterized by gene-specific, real-time PCR (data not
shown). Only four plaques of the 208 plaques screened
were found to be reassortant viruses, and all four came from
the co-infections that had a ratio of 5:1 (ANDV/SNV).
The reassortant viruses that were generated were recip-
rocal exchanges of the M segment between the two viruses.
We recovered two SAS (SNV S segment, ANDV M
segment, and SNV L segment) viruses, designated SAS-
23 and SAS-11; and two ASA viruses. The ASA viruses
were lost on further rounds of amplification, suggesting
instability of these genome segment combinations.
Sequence analysis of the M gene open reading frame
indicated that reassortant SAS-23 had mutations in the M
segment but SAS-11 had wild-type sequence and was
therefore chosen for further analysis. A parental ANDV
(AAA-14) was selected for parallel analysis to ensure that
the reassortant selection process did not alter the virus’
characteristics in any way. No parental SNV was recovered
from the dual infections. This is not surprising as our isolate
of ANDV replicates more efficiently in cell culture than our
isolate of SNVand we were not able to achieve high enough
titers of SNV to perform a dual infection with a large excess
of SNV as compared to ANDV. The parental origins of the
genome segments of the reassortant viruses were confirmed
by RT-PCR followed by restriction analysis (Fig. 1).
It is interesting that only M segment reciprocal ex-
changes occurred with significant frequency. This could
suggest a co-requirement for S and L genome segments. It
is thought that association of the RNA-dependent RNA
polymerase (RdRp-encoded by L) with the encapsidated
RNA requires sequence specificity, and recognition and
displacement of the nucleocapsid protein for replication
and transcription to occur (Schmaljohn and Hooper,
2001). Therefore, the recovery of M segment reassortant
viruses, but not S or L segment reassortant viruses, suggestsVand SNV, an SAS virus. RT-PCR followed by restriction digest analysis of
DV and SNV) and for the reassortant virus SAS-11.
Fig. 2. The reassortant virus that contained the M segment of ANDV had
plaque morphology and growth patterns similar to ANDV. (A–D)
Photographs of plaque assays that were performed on the various viruses
and (E) growth curves of the viruses as determined by plaque assay. (A)
parental ANDV, (B) parental SNV, (C) SAS-11, and (D) AAA-14.
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specificity of the RdRp–N interaction.
Reassortant viruses containing SNV M and ANDV S and
L segments (ASA) were lost after multiple rounds of
growth. One possible explanation for this instability is that
the ANDV RdRp was unable to replicate or transcribe the
SNV M segment with adequate efficiency due to differences
in the SNV and ANDV M genome segment 5V and 3V
nontranslated sequences. For example, the SNV (NM
R11) and ANDV 3V vRNA nontranslated sequences differ
at 11 of the 51 nucleotides (Chizhikov et al., 1995; Meissner
et al., 2002). However, at this point, it is unclear if the
apparent bias toward M segment monoreassortants is due to
inefficient or incompatible RNA and/or protein interactions
as is suggested above, or if it is simply a reflection of small
sample size. Analysis of more reassortant viruses will be
required to clarify this point. Small sample size could also
account for that fact that, unlike others (Rodriguez et al.,
1998), we did not isolate any viruses containing diploid
genome segments.
SAS viruses have ANDV-like plaque morphologies
Hantaviruses do not cause lytic infections in Vero E6
cells; however, infected cells show decreased uptake of
neutral red, allowing for visualization of plaques. Compa-
ring the plaque morphology of the reassortant and parent
viruses revealed that the SAS reassortant virus had large,
sharply defined plaques, similar to those observed with
ANDV (Fig. 2). In contrast, SNV plaques were small and
poorly defined. Thus, the large, sharply defined plaque
morphology associated with ANDV maps to the ANDV
M genome segment.
SAS-11 reassortant virus exhibited ANDV-like growth
patterns in cell culture
The SAS-11 reassortant virus exhibited ANDV-like
growth patterns in culture although it replicated to slightly
lower titers; 106 vs. 107 PFU/ml for parental ANDV (Fig.
2E). ANDV and SAS-11 showed peaks in virus production
between days 4 and 6 postinfection (p.i.) followed by a steady
decline in titer until the end of the experiment. SNV grew to
peak titers of 105 PFU/ml on day 6 and 10 and slowly
declined over the course of the infection. Thus, a partially
enhanced rate-of-growth in cell culture was conferred to SNV
with the substitution of an ANDV M segment.
RNA accumulation is segment-dependent
ANDV and SNV demonstrate different kinetics and
quantities of RNA accumulation during in vitro infections.
To determine if the kinetics of RNA accumulation were
altered in the reassortant viruses, we performed reverse-
transcription real-time PCR using RNA isolated from
infected cells. Hantaviruses contain three negative-senseRNA strands; in an infected cell, both viral replication and
gene expression are occurring; therefore, positive and nega-
tive sense RNAs can be detected. Consistent with the
differences in titer, ANDV infections tend to produce higher
levels of RNA and do so more rapidly than SNV infections
(Fig. 3). The levels of S and L segment RNA for the
reassortant viruses were similar to those of SNV throughout
the infection (Figs. 3A,C). This is consistent with the fact
that the reassortant viruses have SNV S and L segments. In
contrast, the M segment RNA levels were approximately
equivalent for AAA-14 and SAS-11. These data are consis-
tent with the fact that the reassortant viruses have an ANDV
M segment; however, this is a very interesting result as it
suggests that the levels of a particular segment of viral RNA
might be controlled in a cis fashion. In these experiments,
the quantities and accumulation patterns of a given RNA
Fig. 3. Characterization of viruses by real-time PCR. The levels of the six RNA segments that are present in infected cells over a 21-day time course are shown
above. (A) S Segment RNAs. (B) M segment RNAs. (C) L Segment RNAs. The negative-strand data are on the left side and the positive-strand data are on the
right side. Data for each virus SAS-11 (-E-), AAA-14 (-n-), and SNV (--) are shown.
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rather than with the origin of the RdRp. As was mentioned
above, this may be related to the ability of the RdRp to
recognize and initiate replication or transcription from the
RNA template.
SAS viruses are not lethal in Syrian hamsters
Having generated a reassortant virus containing an
ANDV M genome segment in a SNV background, we were
interested in exploring the possibility that the ANDV Mgenome segment might be sufficient to confer the lethal
HPS phenotype associated with parental ANDV. To test this
possibility, we injected Syrian hamsters with a high (20,000
PFU) or low (200 PFU) dose of the reassortant or parental
viruses. The SAS reassortant virus was not lethal at low or
high dose (Fig. 4A). This result indicated that the ANDV M
genome segment was insufficient to confer the lethal HPS
phenotype. Consistent with published findings (Hooper et
al., 2001), SNV did not cause illness or death at any dose,
and ANDV was 100% lethal at both doses (Fig. 4A). The
AAA-14 reassortant was also lethal at high and low doses
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become infected as indicated by the absence of an antibody
response after challenge (see below). The AAA-14 results
demonstrate that multiple rounds of plaque purification and
virus amplification did not affect the virulent phenotype
associated with ANDV.
ELISA performed on sera collected from hamsters post-
challenged with SAS reassortant virus had high levels of
anti-nucleocapsid antibodies (Fig. 4B). Thus, the SAS
reassortant virus was SNV-like in its capacity to asympto-
matically infect hamsters. It was possible (although highly
unlikely) that the biochemistry assays used to identify the
M genome segment in the SAS reassortant viruses as of
ANDV origin were incorrect. We ruled this possibility out
because the SAS reassortant virus elicited high-titer ANDV-
specific neutralizing antibodies indicating that the M ge-
nome segment was, in fact, of ANDVorigin (Fig. 4C). As a
final proof, the M genome segment open reading frame in
the SAS-11 reassortant virus was sequenced and found to be
identical to the M genome segment of the parental ANDV
(data not shown).
SAS and the pathogenesis of HPS
Although we had hoped to generate all six possible types
of ANDV/SNV reassortants, after considerable effort, the
only stable reassortant virus isolated was SAS. Neverthe-
less, this single reassortant virus has provided some inte-
resting insights into the pathogenesis of HPS.
Tropism and virulence
For many viruses, a single protein (virulence factor) can
confer a virulent phenotype on a virus by altering the
tropism of the virus to a particular tissue. This was first
demonstrated using reovirus reassortants whereby the neu-
rovirulence of type 3 reoviruses in mice was mapped to the
S1 genome segment, which encoded the sigma 1 attachment
protein (Weiner et al., 1977). One could hypothesize that the
ANDV and SNV glycoproteins might confer a different
tropism in the hamster (e.g., infect different subsets of
endothelial cells) and that this difference might account
for the dramatic difference in pathology. However, our
results indicate that the ANDV M genome segment was
insufficient to account for the virulent phenotype in hams-
ters. Thus, although we did not rule out the possibility that
the ANDV and SNV glycoproteins might confer different
tropisms in the hamsters (this remains to be studied), any
difference in glycoprotein-mediated tropism on its own
cannot account for the virulent phenotype.Fig. 4. Reassortant virus SAS was not lethal in Syrian hamsters. (A) Survival cur
SNV, AAA-14, and SAS-11. (B) ELISA titers against nucleocapsid protein postcha
1646, the only hamster in an ANDV group to survive, apparently was not infect
hamsters previously shown to be positive for antinucleocapsid antibodies (Hooper
performed on postchallenge sera from hamsters challenged with the low dose of SN
dilution neutralizing 50% of the plaques in control (no serum) well. * indicates tIntracellular pathology and virulence
Hantaviruses do not cause lytic infections in cell culture
or in vivo; however, as can be seen in the neutral red
uptake plaque assay, cells infected with hantaviruses can
be functionally impaired. It is possible that HPS in
hamsters is due to dysfunction of infected endothelial
cells. Immunohistochemistry has demonstrated that lung
endothelial cells of ANDV-infected hamsters contain viral
antigen (Hooper et al., 2001). The pulmonary edema and
pleural effusions associated with HPS in hamsters indicate
that the endothelial cells of the lung capillaries are
dysfunctional. One could hypothesize that the ANDV
and SNV M genome segments confer different capacities
to render an infected endothelial cell dysfunctional, and
that this difference might account for the dramatic differ-
ence in pathology. Indeed, our in vitro data indicate that
the ANDV M genome segment is sufficient to confer a
large, sharply defined plaque morphology to the SAS
reassortant viruses, and growth curves indicate that the
SAS reassortant viruses grow to higher titers than SNV.
However, our results in hamsters indicate that the ANDV
M genome segment was insufficient to account for the
virulent phenotype. Thus, although we have not ruled out
the possibility that the ANDV and SNV glycoproteins
might confer different capacities to render an infected
endothelial cell dysfunctional, any glycoprotein-associated
difference on its own cannot account for the virulent
phenotype in hamsters.
Immunopathology and virulence
Many lines of evidence point toward immunopathology
as the mechanism underlying HPS in humans (reviewed in
Peters and Khan, 2002). One of the most compelling lines
of evidence for an immune-mediated disease is the pres-
ence of activated lymphoblasts in alveoli that contain
antigen in their walls and the absence of immune cells in
the antigen-positive renal medulla and glomeruli (Nolte et
al., 1995; Zaki et al., 1995). These pathology findings
correlate with the pulmonary involvement and lack of
significant renal involvement in most HPS cases. In addi-
tion, the finding that cytokine-producing cells are present in
the alveolar walls and spaces of autopsy specimens has led
to the hypothesis that endothelial cell dysfunction is due to
the presence of cytokines that are produced by infiltrating
immune cells (Mori et al., 1999). Hantavirus infection of
lung microvascular endothelial cells in vitro led to the
production of cytokines, but did not cause a change in
the permeability of endothelial cell monolayers (Sundstrom
et al., 2001) arguing against intracellular pathology causedves postchallenge (day 0) of hamsters with high and low doses of ANDV,
llenge. Empty bars indicate titer <100 and > indicates titer z12800. Hamster
ed. The positive control (positive) was serum collected from SNV-infected
et al., 2001). (C) Neutralizing antibody titers. SNV and ANDV PRNT were
Vor high and low dose of SAS-11. PRNT titers represent the lowest serum
iter is <20.
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studies have correlated the presence of reactive oxygen/
nitrogen species with HPS; however, while these studies
show a strong correlation, they do not address what direct
role these reactive molecules night play in altering vascular
permeability (Davis et al., 2002).
The SAS reassortant virus was highly infectious and
elicited a robust antiglycoprotein immune response as
measured by neutralizing antibodies, and yet it did not
cause HPS in hamsters. These findings demonstrated that,
if immunopathology is a mechanism underlying lethal HPS
in hamsters, then this immunopathology does not map to the
M genome segment alone. Thus, if immunopathology is
responsible for the virulent phenotype, then the ANDV S
and/or L genome segments must play a role either directly
by eliciting a pathogenic immune response themselves, or
by modulating the immune responses to one or more
ANDV-associated immunogens.
Summary
Additional reassortant viruses will be required to defini-
tively map the ANDV/SNV strain difference in the lethal
HPS phenotype in hamsters. It is possible that more than one,
and perhaps all three, ANDV genes will be required for HPS.
For example, suboptimal compatibility between the SNV
polymerase and the ANDV M genome segment could affect
the biological properties of the virus and alter the pathogen-
esis in the hamster. Studies of other viruses in the Bunyavir-
idae family set a precedent for the role of multiple genes in
virulence. Rift Valley fever reassortant viruses demonstrated
that mutations in any segment could lead to attenuation
(Saluzzo and Smith, 1990). Additionally, neurovirulence of
the California serogroup of bunyaviruses was independently
mapped to both the M and L segments (Endres et al., 1991;
Griot et al., 1993).
Our findings that the M genome segment was insufficient
to confer the lethal HPS phenotype rules out several simple
hypotheses of HPS pathogenesis and has turned our attention
to the ANDV L and S genome segments. Perhaps the S and/
or L genome segments alter the tropism or kinetics of ANDV
infection, allowing it to replicate in alternative cell types or
replicate more rapidly in a common cell type, thus resulting
in lethal HPS in the hamster model. Alternatively, the ANDV
S and/or L genome segments might prove to be more toxic in
infected endothelial cells resulting in more marked dysfunc-
tion. For example, a protein product of the ANDV S or L
genome is possibly responsible for its pathogenesis, as was
suggested by the studies with Rift Valley fever virus, which
linked expression of a nonstructural protein (NSs) with
virulence (Vialat et al., 2000). No NSs proteins have ever
been identified in any hantavirus despite attempts by many
investigators (Parrington and Kang, 1990; Spiropoulou et al.,
1994; Stohwasser et al., 1990). However, the ANDV S
segment contains an ambisense ORF that is predicted to
encode an approximately 10-kDa protein, and this ORF is
not present in the SNV S segment. An additional mechanismof pathogenesis might include an immune response to the
ANDV nucleocapsid and/or polymerase that results in lethal
immunopathology or these proteins might somehow down-
regulate an otherwise protective immune response.
The Syrian hamster lethal HPS model combined with
mutant viruses and reassortant viruses such as the SAS
reassortant virus described here will allow us to formulate
and test hypotheses and ultimately elucidate the pathoge-
nesis of HPS in hamsters. It is our hope that this information
can then be used to formulate a testable model of the
pathogenesis of HPS in humans.Materials and methods
Virus and cells
ANDV strain Chile-9717869 (obtained from T. Ksiazek,
Centers for Disease Control) and SNV strain CC107
(Schmaljohn et al., 1995) were propagated in Vero E6 cells
(Vero C1008 ATCC CRL 1586). Cells were maintained in
Eagle minimal essential medium with Earle’s salts (EMEM)
supplemented with 10% fetal bovine serum (FBS), 10 mM
HEPES (pH 7.4), 200 U/ml penicillin, 200 Ag/ml strepto-
mycin, 1 nonessential amino acids (NEAA), 1.5 Ag/ml
amphotericin B, and 50 Ag/ml gentamicin sulfate (cEMEM)
at 37 jC in a 5% CO2 incubator.
Plaque assay and isolation
Virus isolation and determination of viral titer were
achieved by performing plaque assays as previously de-
scribed (Schmaljohn et al., 1983). Briefly, samples were
serially diluted in cEMEM, and 200 Al of each dilution was
applied to duplicate wells of six-well plates containing 7-
day-old Vero E6 cells. The plates were incubated for 1 h at
37 jC, with periodic rocking. Cells were then overlaid with
2 ml of 0.6% agarose in EMEM supplemented with 10%
FBS, 100 U/ml of penicillin, 100 U/ml of streptomycin, 1
NEAA, and 1.5 Ag/ml of amphotericin B. Cells were
incubated at 37 jC for 7 days and then overlaid with the
same concentration of agarose but containing 0.0165%
neutral red. Plaques were counted every day for 3 days after
the second overlay.
Generation of reassortant viruses
Vero E6 cells were simultaneously co-infected with twice
plaque-purified stocks of ANDV and SNV at various multi-
plicities of infection. On days 4, 8, and 10 postinfection,
supernatants were collected and cells were fed with fresh
medium. Reassortant viruses were isolated by plaque assay
as described above. Isolated plaques were collected by
inserting a sterile 1-ml pipet tip into the plaque, and then
the plaque was resuspended in 1 ml of cEMEM. The
resuspended plaque was used to inoculate a T25 of Vero
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a second round of plaque purification as described above.
Genetic analysis of reassortant viruses by RT-PCR and
restriction digestion
RNA was isolated from infected cells on day 10 of the
amplification step using TRIzol (Invitrogen). RT-PCR am-
plification of a portion of each segment followed by restric-
tion digest analysis was performed. RT primers were as
follows: AND/SN S RT (5V-TAG TAG TAG ACT CCT TGA
GAA GC-3V), AND M RT (5V-TAG TAG TAG ACT CCG
CAA G-3V), SN M RT (5V-TAG TAG TAG ACT CCG CAC
G-3V), and AND/SN L RT (5V-TAG TAG TAG ACT CCG
AGA TAG AGA AAG-3V). RT reactions were performed
using Superscript II according to manufacturer’s instructions
(Invitrogen). After reverse transcription, 2 Al of each RT
reaction was used as template in a PCR reaction to amplify
out portions of each viral segment: S, M, and L. The other
PCR reaction components were 1 HiFi buffer, 0.2 mM
dNTPs, 20 ng of each primer, 2 mM MgSO4, and 0.5 Al of
platinum Taq HiFi (Invitrogen). The PCR conditions were
95 jC for 5 min followed by 30 cycles of 95 jC for 30 s,
55 jC for 30 s, 72 jC for 1 min, and finally a 7-min
extension at 72 jC. The following primers were used in
the PCR reactions: AND S 135F (5V-AGT GGA GGT TGG
ACC CGG ATG ACG TTA AC-3V), AND S 643R (5V-TTG
TCC TAA ATC GTC CTG GCG TGA TTT C-3V), SN S
135F (5V-GGT GGA ACT GGA CCC CGATGATGT TAA
C-3V), SN S 646R (5V-CAATTG TAC GGA ACC TCC CAG
GAG TG-3V), AND M 610F (5V-GTC AGT GTT TCA ACC
CAG CAC ACA-3V), AND M 1210R (5V-CTG CTA GTG
TAC AAA AAA CTG TAC ATC-3V), SN M 610F (5V-GGC
TAT GTT TCA TTC CAA CAC ATA C-3V), SN M 1210R
(5V-CCA ATG TACAGAAAA CTG TACAGCC-3V), AND
L 635F (5V-GTT AGA TGA GAG AGC ATC TTT GGA
GGC-3V), AND L 1335R (5V-CTC CAATGT TTATTT CAA
GAT TTG ATA AG-3V), SN L 636F (5V-CCT GAC GAG
CGT GCA TCA TTA GAA GCC-3V), and SN L 1337R (5V-
CTC ACC GAC ATT TAT TTC AAG GTT TG-3V).
The S segment PCR reactions produced an approxi-
mately 500-bp fragment that, when digested by EcoRI or
StuI, allowed for genetic identification. The AND S PCR
product is not susceptible to digestion by EcoRI but a StuI
digest resulted in two fragments: 191 and 316 bp. The SN S
PCR product produced three fragments when cut by EcoRI:
136, 154, and 219 bp; and a StuI digest produced two
fragments: 195 and 316 bp.
The M segment PCR reactions produced an approxi-
mately 600-bp fragment that, when digested with EcoRI or
KpnI, allowed for genetic identification. The AND M PCR
product was not susceptible to digestion by KpnI but an
EcoRI digest produced three fragments: 137, 171, and
291 bp. The SN M PCR product was not susceptible to
digestion by EcoRI but a KpnI digest produced two frag-
ments: 239 and 361 bp.The L segment PCR reactions produced an approxi-
mately 700-bp fragment that, when digested with XbaI,
allowed for genetic identification. XbaI digestion of the
AND L PCR product produced two fragments: 345 and
354 bp, while the SN L PCR product produced three
fragments upon XbaI digestion: 347, 114, and 237 bp.
Genetic analysis of reassortant viruses by real-time PCR
RNA was isolated from infected cells using TRIzol
(Invitrogen). One microgram of each RNA sample was used
in an RT reaction that contained a primer specific for the
negative (forward primers) or positive (reverse primers)
sense strand of each of the six segments (AND or SN-S,
-M, -L). The RT primers were as follows: AND S 350F (5V-
CAT CTC TGA GATATG GGA ATG TCC TGG-3V), AND
S 1114R (5V-CTTAGG TAT GAT TGG TAG AAG GCA G-
3V), AND M 281F (5V-CATACA ACATCTATG GCC CAG
AAG AG-3V), AND M 932R (5V-GCT GTG ATA GGT CCC
ACTATT CTTAAG-3V), AND L 5085F (5V-GCC TAC TCT
TAT ATG ATG TAT TAG G-3V), AND L 5796R (5V-CCT
TGT TCA TTA TGA GGG AAT ATG CAG-3V), SN S 10F
(5V-ACT CCT TGA GAA GCT ACT ACG AC-3V), SN S
605R (5V-ATT GTA GAT TGA GCA GTA GGC ATG-3V),
SN M 2299F (5V-GGC AGA CAG CCA AGT GTT TCT
TTG-3V), SN M 3092R (5V-TCA CAC GCC TTA ATT GAA
GTTATG-3V), SN L 4119F (5V-GGA CCA ATC AAC ACC
GAG TAT ATG-3V), and SN L 4892R (5V-CTC TTT AGT
ACTATA CAG CGA AAC-3V). Five microliters of each RT
reaction was used in triplicate real-time PCR reactions that
also contained 1 TaqMan Universal PCR Master Mix
(Applied Biosystems), 300 nM of gene-specific forward
and reverse primers, and 200 nM of gene-specific probe.
The primers and probes for each of the segments were as
follows: AND S 737F (5V-GGATGG ATC GGATAG AAG
AGT TTC-3V), AND S 803R (5V-GAG GCG ACC TTT GGC
TTA GG-3V), AND S PROBE (5V-6FAM-TGG CTG CAG
AGT GTC-3V), AND M 585F (5V-TTG TGT AAC AGG
TCA GCT GAT TGA G-3V), AND M 658R (5V-GAG CAG
GCT GAG ATA ATG TA ATG T-3V), AND M PROBE (5V-
6FAM-CTG GGT TGA AAC ACT G-3V), AND L 5395F
(5V-TCA ATC AAA CTC GGA GCT TAG TGT T-3V), AND
L 5461R (5V-ACA TTA GGC TTA CCC CAT TCA AAA-
3V), AND L PROBE (5V-6FAM-CCA GCC TCT GTT TTG
A-3V), SN S 251F (5V-CAG CTC AGA AAT TGG CTT CAA
A-3V), SN S 316R (5V-CCT TCA AAT GGT CAT CAG GTT
CA-3V), SN S PROBE (5V-6FAM-CTG TTG ATC CAA
CAG GGA-3V), SN M 2666F (5V-TGT TTG GAG ACC
CTG GTG ATA TC-3V), SN M 2727R (5V-TGT GTG CTC
AGG GCA TCT CA-3V), SN M PROBE (5V-6FAM-TGT
CAA CAA CAA GTG GG-3V), SN L 4452F (5V-CGA TGT
GAA GTA GTA CCT ACA AAA CAT G-3V), SN L 4555R
(5V-ACA GCA GTA ATT GGG TTT TGA ATA GC-3V), and
SN L PROBE (5V-6FAM-CAA GAA CTT TCA CAG TGC
G-3V). Real-time PCR conditions were 2 min at 50 jC and
10 min at 95 jC followed by 40 cycles of 15 s at 95 jC and
A.K. McElroy et al. / Virology 326 (2004) 130–1391381 min at 60 jC. Reactions were run and analyzed on a
7900HT Sequence Detection System (Applied Biosystems).
Establishment of viral growth curves
Vero E6 cells were infected with parental and reassortant
viruses at a moi of 0.1. Cells were collected every other day
for 21 days postinfection, and supernatants were collected
for plaque assay. RNAwas analyzed by RT-real time PCR as
described above and supernatants were analyzed for viral
titer by plaque assay, also described above. RNA was
isolated from the cells using TRIzol (Invitrogen) per the
manufacturer’s instructions.
Infection of hamsters with viruses
Adult, female, Syrian hamsters (Mesocricetus auratus)
(Harlan) were injected intramuscularly (i.m.) (caudal thigh,
25-ga, 5/8-in. needle) with the indicated hantavirus diluted
in 0.2 ml of sterile PBS (pH 7.4) as described previously
(Hooper et al., 2001). A high dose and low dose were used
for all of the viruses that were tested, 20,000 and 200 PFU,
respectively. Work involving infected hamsters was per-
formed in a biosafety level 4 (BSL-4) laboratory. Hamsters
were monitored daily for signs of illness. Blood was
collected just before challenge and on day 37 postchallenge.
ELISA and plaque reduction neutralization assay
Anti-nucleocapsid ELISA were performed as previously
described (Hooper et al., 1999). The antigen was a hista-
dine-tagged truncated Puumala virus (PUUV) nucleocapsid
fusion protein expressed from pPUUSXdelta (provided by
Fredrik Elgh, Umea, Sweden). Antibodies to SNV and
ANDV nucleocapsid cross-react with the PUUV nucleocap-
sid, allowing this antigen to be used to determine relative
anti-nucleocapsid responses in infected hamsters (Hooper
et al., 2001). SNV and ANDV plaque reduction neutraliza-
tion assays were performed as previously described (Hooper
et al., 2001).Acknowledgments
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